These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 27603594)
1. Protoporphyrin IX in the skin measured noninvasively predicts photosensitivity in patients with erythropoietic protoporphyria. Heerfordt IM; Wulf HC Br J Dermatol; 2016 Dec; 175(6):1284-1289. PubMed ID: 27603594 [TBL] [Abstract][Full Text] [Related]
2. Light-provoked skin symptoms on the hands of erythropoietic protoporphyria patients related to personal dosimeter measurements, skin symptoms, light protection and priming. Heerfordt IM; Heydenreich J; Philipsen PA; Lerche CM; Wulf HC J Photochem Photobiol B; 2020 Dec; 213():112054. PubMed ID: 33075648 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality. Wulf HC; Nissen CV; Philipsen PA Photodiagnosis Photodyn Ther; 2020 Mar; 29():101582. PubMed ID: 31809913 [TBL] [Abstract][Full Text] [Related]
4. Trends in erythrocyte protoporphyrin IX concentration by age, sex and season among patients with erythropoietic protoporphyria-20 years of follow-up. Heerfordt IM; Lerche CM; Wulf HC Photodiagnosis Photodyn Ther; 2020 Dec; 32():101928. PubMed ID: 32717453 [TBL] [Abstract][Full Text] [Related]
5. Distribution of protoporphyrin IX in erythrocytes in a case of acquired erythropoietic protoporphyria. Heerfordt IM; Fontenete S; Lerche CM; Wulf HC Photodiagnosis Photodyn Ther; 2022 Mar; 37():102629. PubMed ID: 34798346 [TBL] [Abstract][Full Text] [Related]
6. Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria. Delaby C; Lyoumi S; Ducamp S; Martin-Schmitt C; Gouya L; Deybach JC; Beaumont C; Puy H Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):45-52. PubMed ID: 19268001 [TBL] [Abstract][Full Text] [Related]
8. Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria. Genovese G; Maronese CA; Moltrasio C; Piccinno R; Marletta DA; De Luca G; Graziadei G; Granata F; Di Pierro E; Cappellini MD; Marzano AV Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):141-149. PubMed ID: 34420239 [TBL] [Abstract][Full Text] [Related]
9. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria. Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811 [TBL] [Abstract][Full Text] [Related]
10. Effects of iron supplements in individuals with erythropoietic protoporphyria. Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC Photodiagnosis Photodyn Ther; 2024 Jun; 47():104211. PubMed ID: 38734198 [TBL] [Abstract][Full Text] [Related]
11. The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria. Wang P; Sachar M; Lu J; Shehu AI; Zhu J; Chen J; Liu K; Anderson KE; Xie W; Gonzalez FJ; Klaassen CD; Ma X Sci Adv; 2019 Sep; 5(9):eaaw6127. PubMed ID: 31555729 [TBL] [Abstract][Full Text] [Related]
12. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity. Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024 [TBL] [Abstract][Full Text] [Related]
13. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268 [TBL] [Abstract][Full Text] [Related]
14. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources. Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietic protoporphyria and early onset of cholestasis. Khalili MJ; Farahmand F; Hirbod-Mobarakeh A; Yousefi A; Sotoudeh S; Monajemzadeh M; Razaghian A; Rezaei N Turk J Pediatr; 2012; 54(6):645-50. PubMed ID: 23692792 [TBL] [Abstract][Full Text] [Related]
16. Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics. Hussain Z; Qi Q; Zhu J; Anderson KE; Ma X Pharmacol Ther; 2023 Aug; 248():108487. PubMed ID: 37392940 [TBL] [Abstract][Full Text] [Related]
17. Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria. Parker CJ; Desnick RJ; Bissel MD; Bloomer JR; Singal A; Gouya L; Puy H; Anderson KE; Balwani M; Phillips JD Mol Genet Metab; 2019 Nov; 128(3):309-313. PubMed ID: 31395332 [TBL] [Abstract][Full Text] [Related]
18. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice. Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505 [TBL] [Abstract][Full Text] [Related]
19. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report. Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647 [TBL] [Abstract][Full Text] [Related]
20. Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements. Raef HS; Rebeiz L; Leaf RK; Hughes O; Jiang P; ElSeht A; Anderson KE; Wheeden K; Kochevar I; Elmariah SB; Dickey AK JAMA Dermatol; 2023 Feb; 159(2):204-208. PubMed ID: 36630131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]